| Title |
SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
|
|---|---|
| Published in |
PLOS ONE, August 2010
|
| DOI | 10.1371/journal.pone.0012140 |
| Pubmed ID | |
| Authors |
Kathryn J. Swoboda, Charles B. Scott, Thomas O. Crawford, Louise R. Simard, Sandra P. Reyna, Kristin J. Krosschell, Gyula Acsadi, Bakri Elsheik, Mary K. Schroth, Guy D'Anjou, Bernard LaSalle, Thomas W. Prior, Susan L. Sorenson, Jo Anne Maczulski, Mark B. Bromberg, Gary M. Chan, John T. Kissel |
| Abstract |
Valproic acid (VPA) has demonstrated potential as a therapeutic candidate for spinal muscular atrophy (SMA) in vitro and in vivo. |
Mendeley readers
The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Germany | 1 | <1% |
| Netherlands | 1 | <1% |
| Ireland | 1 | <1% |
| France | 1 | <1% |
| Spain | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 175 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 30 | 16% |
| Other | 23 | 13% |
| Student > Ph. D. Student | 23 | 13% |
| Student > Master | 23 | 13% |
| Student > Bachelor | 19 | 10% |
| Other | 20 | 11% |
| Unknown | 45 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 21% |
| Neuroscience | 18 | 10% |
| Agricultural and Biological Sciences | 17 | 9% |
| Biochemistry, Genetics and Molecular Biology | 16 | 9% |
| Nursing and Health Professions | 10 | 5% |
| Other | 34 | 19% |
| Unknown | 49 | 27% |